Investor Relations
Flow’s Digital therapeutics (DTx) are evidence-based solutions within the wider digital health landscape, delivered directly to patients to prevent, manage or treat a medical disorder or disease. Flow was founded by engineers, physiotherapists and scientists with extensive research experience.